FDA InspectionAurolife Pharma LLC
Aurolife Pharma LLC – FDA Inspection, Apr 10, 2025
Record Details
This FDA Inspection record concerns Aurolife Pharma LLC, with an inspection on April 10, 2025, issued by the Atlanta District Office, covering human drugs.
ID · 23acc2de-8d2d-4ac0-afdf-ed28f994e5d3
Inspection Facts
- Inspection number
- 1265425
- FDA center
- Human Drugs
Other FDA inspections of Aurolife Pharma LLC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| August 26, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 31, 2019 | Not classified | Atlanta District Office |
Comes with the profile
KRA (KeyPedia Risk Analysis)
How likely the FDA is to take enforcement action in the next 12 months.
Example18-month trend
Form 483 · April 10, 2025
What you get
A document
One file.
- One FDA document, such as a Form 483
- Yours for life in your Library
- Each has its own price
The profile
All the documents, plus intelligence about the company.
- Every Aurolife Pharma LLC document on file
- The KRA score, which a single document does not include
- Observations and inspection history
Access
This, for every company on KeyPedia.
- Combine profiles in one search
- Search across any modality: products, industry types, drugs, devices and recalls
- Track everything as it changes
- Other agencies too, such as EMA, Health Canada and UK MHRA